Cannara Biotech (TSX:LOVE) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSX:LOVE Cannara Biotech Inc TSX:LOVE
84 GF Score
Price C$1.98
GF Value C$1.70
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Cannara Biotech Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

TSX:LOVE vs ZTS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cannara Biotech's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannara Biotech Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannara Biotech's Short Interest distribution charts can be found below:

* The bar in red indicates where Cannara Biotech's Short Interest falls into.


TSX:LOVE
84GF Score
Cannara Biotech Inc TSX:LOVE
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cannara Biotech (TSX:LOVE) Overvalued in 2026?

Based on GuruFocus' analysis, Cannara Biotech stock appears to be overvalued. The current stock price of C$1.98 is trading 16.5% above its estimated GF Value™ of C$1.70. GuruFocus considers Cannara Biotech to be Modestly Overvalued.

Key valuation signals for TSX:LOVE:

  • Short Interest:
  • GF Value™: C$1.70 vs. price of C$1.98 (16.5% above fair value)
  • GF Score™: 84/100 with 6 warning signs

No single metric tells the full story. See the TSX:LOVE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cannara Biotech Business Description

Other Exchanges LOVFF:USA8CB0:Germany
Address 1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3
Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .
84GF Score

Get the complete analysis for TSX:LOVE

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.98
Price
C$1.70
GF Value